Prostatype Genomics AB (publ) (STO:PROGEN)
0.1220
+0.0065 (5.63%)
Sep 25, 2026, 5:29 PM CET
Prostatype Genomics AB Employees
Prostatype Genomics AB had 7 employees as of June 30, 2026. The number of employees did not change since the number was reported on December 31, 2025.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
115.00K SEK
Profits / Employee
-5.41M SEK
Market Cap
68.33M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 7 | 0 | - |
| Dec 31, 2025 | 7 | 1 | 16.67% |
| Dec 31, 2024 | 6 | 0 | - |
| Dec 31, 2023 | 6 | 0 | - |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Medicover AB | 49,000 |
| Getinge AB | 11,758 |
| Swedish Orphan Biovitrum AB | 2,119 |
| Sectra AB | 1,403 |
| Clinical Laserthermia Systems AB | 13 |
| AcouSort AB | 11 |
| Newbury Pharmaceuticals AB | 7 |
| Spago Nanomedical AB | 6 |
Prostatype Genomics AB News
- 26 days ago - Prostatype Genomics AB Quarterly report: Q2 2026 - Filings
- 7 months ago - Prostatype Genomics AB Quarterly report: Q4 2025 - Filings
- 7 months ago - Prostatype Genomics AB Annual report: Q4 2025 - Filings
- 10 months ago - Prostatype Genomics AB Transcript: Life Science Summit 2025 - Transcripts